MARKET

FMS

FMS

Fresenius Care
NYSE

Real-time Quotes | Nasdaq Last Sale

35.55
+0.20
+0.57%
After Hours: 35.55 0 0.00% 16:00 09/17 EDT
OPEN
35.52
PREV CLOSE
35.35
HIGH
35.64
LOW
35.27
VOLUME
278.64K
TURNOVER
--
52 WEEK HIGH
44.13
52 WEEK LOW
31.50
MARKET CAP
20.83B
P/E (TTM)
17.61
1D
5D
1M
3M
1Y
5Y
Fresenius Medical Care Partners with JMS Co. Ltd. to Advance Home Dialysis Treatment in Japan
HONG KONG, September 17, 2021--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has today announced a strategic distribution partnership with JMS Co. Ltd, a provider of medical devices and p...
Business Wire · 22h ago
Fresenius Medical Care Selects JMS Co. as Distributor of Home Dialysis Systems in Japan
MT Newswires · 1d ago
Barclays adds ‘very cheap’ global stocks to its inflation-beating list
Barclays has added seven new stocks to its European value basket, which it says is well-placed to provide investors with a hedge against rising inflation.
CNBC.com · 4d ago
European markets inch higher as global sentiment rebounds; Rubis down 6%
European markets were cautiously higher on Friday, tracking global counterparts as sentiment rebounded following a rocky week.
CNBC.com · 09/10 13:04
UPDATE 1-European stocks gain on tech and luxury boost, but set for weekly losses
reuters.com · 09/10 08:22
LIVE MARKETS-Pay raise: from main street to Wall Street
reuters.com · 09/03 10:33
After NASDAQ Debut, Humacyte's Investor Adds $25M Infusion
Benzinga · 08/31 14:01
Fresenius Medical Care Invests An Additional $25 Million in Humacyte
MT Newswires · 08/30 11:35
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FMS. Analyze the recent business situations of Fresenius Care through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FMS stock price target is 40.62 with a high estimate of 45.71 and a low estimate of 35.17.
EPS
Institutional Holdings
Institutions: 266
Institutional Holdings: 21.42M
% Owned: 3.66%
Shares Outstanding: 585.96M
TypeInstitutionsShares
Increased
54
2.16M
New
28
369.56K
Decreased
45
1.11M
Sold Out
20
394.31K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.60%
Healthcare Providers & Services
+0.93%
Key Executives
Chairman - Supervisory/Director
Dieter Schenk
Chairman - Management/Chief Executive Officer
Rice Powell
Non-Executive Chairman
Ben Lipps
Vice Chairman - Supervisory/Independent Director
Rolf Classon
Chief Financial Officer/Management Board
Helen Giza
Vice President - Research & Development/Management Board
Olaf Schermeier
Corporate Executive
Harry De Wit
Management Board
Harry de Wit
Management Board
Frank Maddux
Management Board
Katarzyna Mazur-Hofsaess
Management Board
William Valle
Management Board
Kent Wanzek
Independent Director/Supervisory Board
William Johnston
Independent Director/Supervisory Board
Dorothea Wenzel
Supervisory Board
Deborah McWhinney
Independent Director/Supervisory Board
Pascale Witz
Supervisory Board
Gregor Zuend
Supervisory Board
Gregor Zund
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.573191
05/24/2021
08/12/2020
Dividend USD 0.497802
08/28/2020
05/08/2019
Dividend USD 0.450194
05/17/2019
05/10/2018
Dividend USD 0.427
05/21/2018
05/17/2017
Dividend USD 0.37
05/11/2017
05/16/2016
Dividend USD 0.313
05/10/2016
05/21/2015
Dividend USD 0.298
05/15/2015
05/19/2014
Dividend USD 0.368
05/13/2014
05/20/2013
Dividend USD 0.334
05/14/2013
  • All
  • Financials
  • Insiders
More
About FMS
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Webull offers kinds of Fresenius Medical Care AG & Co. KGaA stock information, including NYSE:FMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FMS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FMS stock methods without spending real money on the virtual paper trading platform.